EUVIMEDEUVIMED entdecken
Crossref

TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma

Yosuke Tamura, Shigeru Kawabata, Ryutaro Yamaguchi, Yuki Asai, Shoichi Ishikawa, Kazuhiro Takezaki, Hideaki Kawaguchi, Akira Yura, Yasuyuki Shimazu, Masahiro Arai, Sho Mitsuya, Tomoya Funamoto und 6 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.17958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yosuke Tamura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; yosuke.tamura@ompu.ac.j…. Hauptthemen laut MEDLINE: Pemetrexed, Adenocarcinoma of Lung, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemetrexedAdenocarcinoma of LungAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsThyroid Nuclear Factor 1HumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overPrognosisTreatment OutcomePlatinum

Stichwörter der Autor:innen

Chemoimmunotherapylocation of the primary tumorlung adenocarcinomathyroid transcription factor-1

Substanzen

PemetrexedpembrolizumabAntibodies, Monoclonal, HumanizedThyroid Nuclear Factor 1NKX2-1 protein, humanPlatinum

Autor:innen und Institutionen

  • Department of Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan; yosuke.tamura@ompu.ac.jp.
  • Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.

Zitieren

APA

Tamura, Y., Kawabata, S., Yamaguchi, R., Asai, Y., Ishikawa, S., Takezaki, K., Kawaguchi, H., Yura, A., Shimazu, Y., Arai, M., Mitsuya, S., Funamoto, T., Tsuji, H., Matsunaga, N., Tsuruoka, K., Nakamura, T., Ikeda, S., & Fujisaka, Y. (2026). TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17958

Vancouver

Tamura Y, Kawabata S, Yamaguchi R, Asai Y, Ishikawa S, Takezaki K, et al. TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma. Anticancer Research. 2026. doi:10.21873/anticanres.17958

BibTeX
@article{Tamura2026,
  author = {Tamura, Yosuke and Kawabata, Shigeru and Yamaguchi, Ryutaro and Asai, Yuki and Ishikawa, Shoichi and Takezaki, Kazuhiro and Kawaguchi, Hideaki and Yura, Akira and Shimazu, Yasuyuki and Arai, Masahiro and Mitsuya, Sho and Funamoto, Tomoya and Tsuji, Hiroyuki and Matsunaga, Ninso and Tsuruoka, Kenjiro and Nakamura, Takahiko and Ikeda, Soichiro and Fujisaka, Yasuhito},
  title = {TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17958}
}
Kostenlos starten →